Cumulative live birth and surplus embryo incidence after frozen-thaw cycles in PCOS: how many oocytes do we need?
نویسندگان
چکیده
منابع مشابه
How many Decomposition Types do we need ?
Decision Diagrams (DDs) are used in many applications in CAD. Various types of DDs, e.g. BDDs, FDDs, KFDDs, di er by their decomposition types. In this paper we investigate the di erent decomposition types and prove that there are only three that really help to reduce the size of DDs.
متن کاملHow many PET tracers do we need?
The recognized need for new PET tracers is associated with increases in available PET instrumentation and with unmet clinical challenges in the early diagnosis and staging of diseases. The clinical success of (18)F-FDG PET has resulted in the acceptance of biologic signals as part of disease management. The advantages of PET technology over SPECT will lead to the introduction of new PET tracers...
متن کاملHow Many Diagnoses Do We Need?
A known limitation of many diagnosis algorithms is that the number of diagnoses they return can be very large. This raises the question of how to use such a large set of diagnoses. For example, presenting hundreds of diagnoses to a human operator (charged with repairing the system) is meaningless. In various settings, including decision support for a human operator and automated troubleshooting...
متن کاملHow many cath labs do we need?
T he National Service Framework (NSF) for coronary heart disease (CHD) states that: " By international standards, the UK has high rates of CHD but low rates of coronary artery revascularisation. This does not appear to be because most other countries are over-using revascularisation but rather there has been under-provision of revascularisation in the UK. Another major difference between the UK...
متن کاملHow many grails do we need?
In a classic mixed metaphor of Greek and more recent continental lore, restenosis has been called the Achilles’ heel of interventional cardiology and the solution to restenosis has been called the holy grail. Restenosis itself has been the target of a multiplicity of initiatives, starting with trials of established drugs in the early 1980s, then moving more broadly to trials of many newer and d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Assisted Reproduction and Genetics
سال: 2017
ISSN: 1058-0468,1573-7330
DOI: 10.1007/s10815-017-0959-6